129 related articles for article (PubMed ID: 32066632)
1. Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives.
Carvalho J; Oliveira P; Senz J; São José C; Hansford S; Teles SP; Ferreira M; Corso G; Pinheiro H; Lemos D; Pascale V; Roviello F; Huntsman D; Oliveira C
J Med Genet; 2021 Jan; 58(1):1-11. PubMed ID: 32066632
[TBL] [Abstract][Full Text] [Related]
2. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.
Garcia-Pelaez J; Barbosa-Matos R; São José C; Sousa S; Gullo I; Hoogerbrugge N; Carneiro F; Oliveira C
Eur J Med Genet; 2022 Jan; 65(1):104401. PubMed ID: 34871783
[TBL] [Abstract][Full Text] [Related]
3. E-Cadherin (CDH1) and p53 rather than SMAD4 and Caspase-10 germline mutations contribute to genetic predisposition in Portuguese gastric cancer patients.
Oliveira C; Ferreira P; Nabais S; Campos L; Ferreira A; Cirnes L; Alves CC; Veiga I; Fragoso M; Regateiro F; Dias LM; Moreira H; Suriano G; Machado JC; Lopes C; Castedo S; Carneiro F; Seruca R
Eur J Cancer; 2004 Aug; 40(12):1897-903. PubMed ID: 15288293
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and cancer risk in families with pathogenic
Xicola RM; Li S; Rodriguez N; Reinecke P; Karam R; Speare V; Black MH; LaDuca H; Llor X
J Med Genet; 2019 Dec; 56(12):838-843. PubMed ID: 31296550
[TBL] [Abstract][Full Text] [Related]
5. Is gastric cancer part of the tumour spectrum of hereditary non-polyposis colorectal cancer? A molecular genetic study.
Gylling A; Abdel-Rahman WM; Juhola M; Nuorva K; Hautala E; Järvinen HJ; Mecklin JP; Aarnio M; Peltomäki P
Gut; 2007 Jul; 56(7):926-33. PubMed ID: 17267619
[TBL] [Abstract][Full Text] [Related]
6. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
8. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
9. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
[TBL] [Abstract][Full Text] [Related]
10. Somatic mutations and deletions of the E-cadherin gene predict poor survival of patients with gastric cancer.
Corso G; Carvalho J; Marrelli D; Vindigni C; Carvalho B; Seruca R; Roviello F; Oliveira C
J Clin Oncol; 2013 Mar; 31(7):868-75. PubMed ID: 23341533
[TBL] [Abstract][Full Text] [Related]
11. High incidence of familial gastric cancer in Tuscany, a region in Italy.
Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Suriano G; Vindigni C; Berardi A; Garosi L; De Stefano A; Leoncini L; Seruca R; Pinto E
Oncology; 2007; 72(3-4):243-7. PubMed ID: 18185018
[TBL] [Abstract][Full Text] [Related]
12. Familial gastric cancer: clinicopathological characteristics, RER phenotype and germline p53 and E-cadherin mutations.
Shinmura K; Kohno T; Takahashi M; Sasaki A; Ochiai A; Guilford P; Hunter A; Reeve AE; Sugimura H; Yamaguchi N; Yokota J
Carcinogenesis; 1999 Jun; 20(6):1127-31. PubMed ID: 10357799
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer: new genetic developments.
Lynch HT; Grady W; Suriano G; Huntsman D
J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
[TBL] [Abstract][Full Text] [Related]
14. Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer.
Donner I; Kiviluoto T; Ristimäki A; Aaltonen LA; Vahteristo P
Fam Cancer; 2015 Jun; 14(2):241-6. PubMed ID: 25576241
[TBL] [Abstract][Full Text] [Related]
15. Desmoglein 2 is expressed abnormally rather than mutated in familial and sporadic gastric cancer.
Biedermann K; Vogelsang H; Becker I; Plaschke S; Siewert JR; Höfler H; Keller G
J Pathol; 2005 Oct; 207(2):199-206. PubMed ID: 16025435
[TBL] [Abstract][Full Text] [Related]
16. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria.
Brooks-Wilson AR; Kaurah P; Suriano G; Leach S; Senz J; Grehan N; Butterfield YS; Jeyes J; Schinas J; Bacani J; Kelsey M; Ferreira P; MacGillivray B; MacLeod P; Micek M; Ford J; Foulkes W; Australie K; Greenberg C; LaPointe M; Gilpin C; Nikkel S; Gilchrist D; Hughes R; Jackson CE; Monaghan KG; Oliveira MJ; Seruca R; Gallinger S; Caldas C; Huntsman D
J Med Genet; 2004 Jul; 41(7):508-17. PubMed ID: 15235021
[TBL] [Abstract][Full Text] [Related]
17. Monogenic and polygenic determinants of sarcoma risk: an international genetic study.
Ballinger ML; Goode DL; Ray-Coquard I; James PA; Mitchell G; Niedermayr E; Puri A; Schiffman JD; Dite GS; Cipponi A; Maki RG; Brohl AS; Myklebost O; Stratford EW; Lorenz S; Ahn SM; Ahn JH; Kim JE; Shanley S; Beshay V; Randall RL; Judson I; Seddon B; Campbell IG; Young MA; Sarin R; Blay JY; O'Donoghue SI; Thomas DM;
Lancet Oncol; 2016 Sep; 17(9):1261-71. PubMed ID: 27498913
[TBL] [Abstract][Full Text] [Related]
18. CDH1/E-cadherin germline mutations in early-onset gastric cancer.
Bacani JT; Soares M; Zwingerman R; di Nicola N; Senz J; Riddell R; Huntsman DG; Gallinger S
J Med Genet; 2006 Nov; 43(11):867-72. PubMed ID: 16801346
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.
Chen I; Mathews-Greiner L; Li D; Abisoye-Ogunniyan A; Ray S; Bian Y; Shukla V; Zhang X; Guha R; Thomas C; Gryder B; Zacharia A; Beane JD; Ravichandran S; Ferrer M; Rudloff U
J Transl Med; 2017 May; 15(1):92. PubMed ID: 28460635
[TBL] [Abstract][Full Text] [Related]
20. Identification of the potential molecular mechanism and driving mutations in the pathogenesis of familial intestinal gastric cancer by whole exome sequencing.
Chen H; Wang J; Zhuang Y; Wu H
Oncol Rep; 2018 Oct; 40(4):2316-2324. PubMed ID: 30106433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
